We
consent to the incorporation by reference in this Registration Statement of Nile
Therapeutics, Inc. on Form S-3 of our report dated March 2, 2010, on the
financial statements of Nile Therapeutics, Inc. as of December 31, 2009 and
for the year then ended, and for the period from August 1, 2005 (inception)
through December 31, 2009 (which report expresses an unqualified opinion
and includes and explanatory paragraph relating to Nile Therapeutics, Inc.’s
ability to continue as a going concern) appearing in the 2009 Form 10-K of Nile
Therapeutics, Inc. and to the reference to us under the heading “Experts” in the
prospectus.